TGFB1 and cancer: In this context, it is noteworthy that MAb-mediated neutralization of two of the three isoforms of TGF-β, viz. TGF-β1 and TGF-β2, was found to potentiate both vaccine and PD-1-targeted immunotherapy in a murine model of experimental cancer therapy (37).